Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6066974 | 0.84 | ALDH1A1 (0.38) | ALDH1A1TGFBR1 | |
| SCHEMBL168292 | 0.82 | ALDH1A1 (0.39) | ALDH1A1TGFBR1 | |
| SCHEMBL6067477 | 0.81 | THRB (0.35) | ALDH1A1TGFBR1 | |
| SCHEMBL170046 | 0.79 | ALDH1A1 (0.39) | ALDH1A1TGFBR1 | |
| SCHEMBL914270 | 0.79 | KDM4E (0.37) | ALDH1A1 | |
| SCHEMBL25389669 | 0.78 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL24024113 | 0.77 | TGFBR1 (0.35) | ALDH1A1TGFBR1TDP1 | |
| SCHEMBL25389099 | 0.77 | KDM4E (0.39) | ALDH1A1 | |
| SCHEMBL25388356 | 0.77 | KDM4E (0.39) | ALDH1A1 | |
| SCHEMBL23455661 | 0.74 | ALDH1A1 (0.32) | ALDH1A1TGFBR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250179251-A1 | COMPOSITION COMPRISING METHACRYLAMIDE GROUP-CONTAINING ORGANIC SILICON COMPOUND AND ARTICLE SURFACE-TREATED WITH SAID COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-06-05 | — | — | US | disclosed |
| WO-2006087079-A1 | COMPOSITIONS CURED BY MICHAEL ADDITION REACTION | Consortium für elektrochemische Industrie GmbH (DE) | 2006-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250179251-A1 | COMPOSITION COMPRISING METHACRYLAMIDE GROUP-CONTAINING ORGANIC SILICON COMPOUND AND ARTICLE SURFACE-TREATED WITH SAID COMPOSITION | CHRM1, CHRM2, CD68 | ALDH1A1 2154/4885TGFBR1 1132/4885HSD17B10 3990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.